Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
6.29
+0.27 (4.49%)
At close: Dec 3, 2025, 4:00 PM EST
6.30
+0.01 (0.16%)
After-hours: Dec 3, 2025, 4:00 PM EST

Aura Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
399411436389496-
Upgrade
Market Cap Growth
-19.79%-5.92%12.22%-21.59%--
Upgrade
Enterprise Value
247255308298631-
Upgrade
Last Close Price
6.028.228.8610.5016.98-
Upgrade
PB Ratio
2.422.701.931.993.26-
Upgrade
P/TBV Ratio
2.502.701.931.993.26-
Upgrade
Debt / Equity Ratio
0.110.120.090.110.01-
Upgrade
Quick Ratio
8.6010.1318.3018.0620.276.54
Upgrade
Current Ratio
9.0410.7718.7618.8120.906.94
Upgrade
Return on Equity (ROE)
-64.27%-46.01%-36.26%-33.78%-41.07%-88.60%
Upgrade
Return on Assets (ROA)
-35.84%-27.46%-22.18%-19.63%-24.19%-46.92%
Upgrade
Return on Capital (ROIC)
-38.49%-28.87%-23.00%-20.39%-25.52%-55.32%
Upgrade
Return on Capital Employed (ROCE)
-66.20%-57.40%-35.00%-28.20%-23.10%-114.20%
Upgrade
Earnings Yield
-27.22%-21.17%-17.51%-15.11%-7.11%-
Upgrade
FCF Yield
-22.70%-19.74%-14.79%-14.32%-6.96%-
Upgrade
Buyback Yield / Dilution
-15.97%-25.32%-32.34%-480.18%-1305.21%-8.54%
Upgrade
Updated Nov 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q